Albert Jang, Jake N. Lichterman, Jeffrey Y. Zhong, Jonathan E. Shoag, Jorge A. Garcia, Tian Zhang, & Pedro C. Barata. (2023). Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma. Taylor & Francis Group.
Chicago Style (17th ed.) CitationAlbert Jang, Jake N. Lichterman, Jeffrey Y. Zhong, Jonathan E. Shoag, Jorge A. Garcia, Tian Zhang, and Pedro C. Barata. Immune Approaches Beyond Traditional Immune Checkpoint Inhibitors for Advanced Renal Cell Carcinoma. Taylor & Francis Group, 2023.
MLA (9th ed.) CitationAlbert Jang, et al. Immune Approaches Beyond Traditional Immune Checkpoint Inhibitors for Advanced Renal Cell Carcinoma. Taylor & Francis Group, 2023.
Warning: These citations may not always be 100% accurate.